Research into how the brain suffers as a result of chemotherapy is revealing potential avenues for ameliorating cognitive decline.
Research into how the brain suffers as a result of chemotherapy is revealing potential avenues for ameliorating cognitive decline.
Researcher salaries continue to buck the trend of the millennium’s first decade, remaining flat or even declining across most life science disciplines.
Epigenetic changes accrued over an organism’s lifetime may leave a permanent heritable mark on the genome, through the help of long noncoding RNAs.
The remarkable ability of the star-nosed mole to interpret its surroundings through touch is yielding clues about mammalian sensory processing in general.
Scientists hope an understanding of nerve fibers responsive only to gentle touch will give insight into the role the sense plays in social bonding.
On the 10th anniversary of The Scientist’s survey of life science academics, institutions are contending with tighter budgets and larger administrative staffs, while working to sustain and inspire their researchers.
After 20 years of high-profile failure, gene therapy is finally well on its way to clinical approval.
Two key pieces of legislation, enacted to spur drugmakers into testing pharmaceutical products in children, are up for reauthorization in the US Congress this October. Have they done their jobs?
When children need medications, getting the dosing and method of administration right is like trying to hit a moving target with an untried weapon.
Examples of parasites that manipulate the behavior of their hosts are not hard to come by, but scientists have only recently begun to understand how they induce such dramatic changes.